Capecitabine and Lenvatinib With External Radiation in Rectal Adenocarcinoma

NCT02935309 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Rectal Cancer
Rectal Adenocarcinoma

Interventions

DRUG: Lenvatinib
DRUG: Capecitabine
RADIATION: External Radiation Therapy (XRT)

Sponsor

H. Lee Moffitt Cancer Center and Research Institute